GUERBET chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 58.52
Dividend & Yield0.85€ (4.48%)
Beta 0.74
Market capitalization 249.38M
Operating cash flow 67.08M
ESG Scores unknown

Company description

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was founded in 1926 and is headquartered in Villepinte, France.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio1.24
Working Capital0.13
Return On Equity0.08
Debt To Equity0.74
Fixed Asset Ratio-0.13
Fixed Interest Cover13.97

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 4.47M -11.38M 4.61M 16.04M
Total Cashflows From Investing Activities -67.3M -65.05M -57.29M -52.24M
Net Borrowings 34.57M -55.44M -33.27M -27.81M
Total Cash From Financing Activities 13.84M -72.73M -46.89M -41.28M
Change To Operating Activities 3.15M -4.44M -3.44M -880k
Issuance Of Stock 276k 230k 100k 592k
Net Income 46.82M 37.33M 18.24M 32.64M
Change In Cash 21.3M -5.07M 12.56M 22.52M
Effect Of Exchange Rate -2.16M 1.44M -3.7M 68k
Total Cash From Operating Activities 76.92M 131.27M 120.43M 115.97M
Depreciation 38.75M 49.1M 49.87M 45.78M
Change To Account Receivables 1.96M 2.99M 14.01M -6.64M
Other Cashflows From Financing Activities -10.3M -6.87M -4.89M -5.25M
Change To Netincome -21.54M 1.9M 9.97M 14.29M
Capital Expenditures -32.72M -38.92M -39.79M -37.5M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 66.44M 51.21M 22.25M 28.97M
Net Income 46.82M 37.33M 18.24M 32.64M
Selling General Administrative 457.4M 466.39M 419.77M 407.75M
Gross Profit 580.83M 597.51M 529.41M 524.37M
Ebit 66.09M 52.86M 42.8M 39.42M
Operating Income 66.09M 52.86M 42.8M 39.42M
Interest Expense -6.9M -7.62M -7.24M -3.24M
Income Tax Expense 19.62M 13.88M 4.01M -3.66M
Total Revenue 794.61M 819M 716.67M 735.91M
Cost Of Revenue 213.78M 221.5M 187.26M 211.54M
Total Other Income ExpenseNet 343k -1.66M -20.55M -10.45M
Net Income From Continuing Ops 46.82M 37.33M 18.24M 32.64M
Net Income Applicable To Common Shares 46.82M 37.33M 18.24M 32.64M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 714.05M 619.67M 577.95M 595.74M
Total Stockholder Equity 366.76M 389.19M 367.75M 405.09M
Other Current Liabilities 92.35M 54.53M 46.1M 63.36M
Total Assets 1.08B 1.01B 945.71M 1B
Common Stock 12.58M 12.6M 12.6M 12.64M
Other Current Assets 63.86M 46.79M 47.09M 50.77M
Retained Earnings 105.9M 185.03M 18.24M 32.64M
Treasury Stock 237.37M 180.44M 336.91M 359.81M
Cash 106.76M 81.42M 96.71M 115.73M
Total Current Liabilities 449.54M 215.93M 200.22M 236.87M
Other Stockholder Equity 237.37M 180.44M 336.91M 359.81M
Property, Plant, and Equipment 254.91M 272.78M 261.29M 274.05M
Total Current Assets 606.55M 515.23M 468.56M 495.45M
Net Tangible Assets 184.39M 199.44M 179.49M 216.47M
Net Receivables 145.93M 140.34M 111.04M 118.78M
Accounts Payable 81.8M 67.76M 64.41M 81.02M


Insider Transactions

Here are the insider transactions of stock shares related to GUERBET:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to GUERBET. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on GUERBET

Here is the result of two systematic investment strategies applied to GUERBET. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on GUERBET

The following chart shows the equity curve of the two systematic investment strategies applied to GUERBET:

GUERBET automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -4.01% on the backtest period.

Performance at glance

Performance

-4.01 %

Latent gain

-71.15 €

Invested capital

1773.15 €

Annualized return

-0.98 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on GUERBET

This is the result of two momentum investment strategies applied to GUERBET. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on GUERBET

The following chart shows all the entries opened by the momentum investment system on GUERBET:

GUERBET momentum entries
  • The first momentum investment strategy would give -12.41% of return on GUERBET. That represents -581.7€ of latent gain with 4688.7€ of employed capital.
  • The second momentum investment strategy would give -8.53% of return on GUERBET. That represents -338.1€ of latent gain with 3964.1€ of employed capital.
Performance at glance (1Q Momentum)

Performance

-12.41 %

Latent gain

-581.7 €

Invested capital

4688.7 €

Annualized return

2.47 %
Performance at glance (2Q Momentum)

Performance

-8.53 %

Latent gain

-338.1 €

Invested capital

3964.1 €

Annualized return

-2.37 %

Momentum equity curve on GUERBET

The following chart shows the equity curve of the two momentum strategies applied to GUERBET:

GUERBET momentum equity

Note: the dividends potentially given by GUERBET are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on GUERBET

The following chart shows the employed capital evolution of the two momentum strategies on GUERBET since the beginning:

GUERBET

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on GUERBET

Buy the dip entry openings on GUERBET

GUERBET

The performance achieved by the robo-advisor on GUERBET is 5.13%. That represents 52.4$ of latent gain with 1020.6€ of employed capital. The following chart shows GUERBET stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of GUERBET, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

5.13 %

Latent gain

52.4 €

Invested capital

1020.6 €

Annualized return

2.47 %

Equity curve of the strategy applied to GUERBET

The following chart shows the result of the investment strategy applied to GUERBET:

GUERBET

Note: the dividends potentially given by GUERBET are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on GUERBET

The following chart shows the employed capital evolution since the beginning of the investment strategy on GUERBET:

GUERBET

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on GUERBET

In this section, I will compare the three previous investment strategies applied to GUERBET.

Equity curve comparison on GUERBET

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

GUERBET investment strategy comparison

Employed capital comparison on GUERBET

GUERBET investment comparison

Performance comparison on GUERBET

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -4.01% -71.15€ 1773.15€ -0.98%
Momentum 1 quarter -12.41% -581.7€ 4688.7€ -3.23%
Momentum 2 quarters -8.53% -338.1€ 3964.1€ -2.37%
Non-directional 5.13% 52.4€ 1020.6€ 2.47%
Annualized return comparison

Automatic investment

-0.98 %

Momentum 1Q

-2.37 %

Momentum 2Q

-2.37 %

Non-directional

2.47 %

Correlated stocks

Here are the most positively and negatively correlated stocks with GUERBET:

Positive correlations

Most correlated stocks this year

  • GUERBET

  • Most correlated stocks last 3 months

  • CRCAM ILLE-VIL.CCI
  • GUERBET
  • EKINOPS
  • PIERRE VACANCES
  • SPDR Homebuilders ETF

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between GUERBET and the other stocks. There may be false positives or some missing correlated stocks. If the price of GUERBET does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name GUERBET
    Country France
    City Villepinte
    Address 15, rue des Vanesses
    Phone 33 1 45 91 50 00
    Website www.guerbet.com
    FullTime employees 2730
    Industry Medical Devices
    Sector Healthcare
    Exchange XPAR
    Ticker GBT.XPAR
    Market www.euronext.com

    GUERBET ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown